Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating ocular disorders by administering a VEGF-binding antibody covalently linked to a hyaluronic acid polymer

Methods of treating ocular disorders by administering a VEGF-binding antibody covalently linked to a hyaluronic acid polymer

US Patent 11891437 · Granted Feb 6, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CD96 antibodies and methods of use thereof2025
Optimized variants of anti-VEGF antibodies2024
Optimized variants of anti-VEGF antibodies2024
Optimized variants of anti-VEGF antibodies2024
Optimized variants of anti-VEGF antibodies2024
Optimized variants of anti-VEGF antibodies2024
Anti-ULBP6 antibodies2024
Anti-ULBP6 antibodies2024
Dual specific antibodies for binding interleukin 4 (IL4) and interleukin 5 (IL5)2024
Dual specific antibodies for binding interleukin 4 (IL4) and interleukin 5 (IL5)2024
Dual specific antibodies for binding interleukin 4 (IL4) and interleukin 5 (IL5)2024
Anti-IL-36 antibodies and methods of use thereof2024